__NUXT_JSONP__("/drugs/Azimexon", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"64118-86-1",chebiId:"",chemicalFormula:"C9H14N4O",definition:"Azimexon (2-cyanaziridinyl-2-carbamoyl-aziridinyl-1-propane) is a derivative of 2-cyanaziridine. Immunostimulant which shows therapeutic effects in tumor models and experimental infections in vitro, enhancing T lymphocyte transformation and phagocytosis. The mode of action of azimexon is unknown. It has been suggested that azimexon may alkylate DNA. In cancer patients it increases leukocytosis, blood active T rosettes, T4\u002FT8 ratio, and is used as an adjuvant to chemotherapy in the treatment of melanoma and myeloma.",fdaUniiCode:"4NJ842U6BZ",identifier:"C1347",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C2080","C2139","C797"],synonyms:["2-Aziridinecarboxamide, 1-[1-(2-cyano-1-aziridinyl)-1-methylethyl]","2-Cyanaziridinyl-2-carbamoyl-aziridinyl-1-propane","AZ","AZIMEXON",a,"Azimexone","BM 12.531","BM12531"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAzimexon",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Azimexon","2021-10-30T13:31:50.793Z")));